Am J Psychiatry 156:1164-1169, August 1999
© 1999 American Psychiatric Association
Clinical Outcome in a Randomized 1-Year Trial of Clozapine Versus Treatment as Usual for Patients With Treatment-Resistant Illness and a History of Mania
Trisha Suppes, M.D., Ph.D.,
Andrew Webb, B.A.,
Betty Paul, L.V.N.,
Thomas Carmody, Ph.D.,
Helena Kraemer, Ph.D., and
A. John Rush, M.D.
OBJECTIVE: Case series and follow-up studies suggest that clozapine may have mood-stabilizing properties in addition to antipsychotic action in patients with schizoaffective disorder, bipolar type, and bipolar I disorder, but the generalizability of these findings is limited. This article describes a randomized, open study of clozapine add-on therapy versus treatment as usual for patients with treatment-resistant illness and a history of mania. METHOD: Thirty-eight patients meeting the DSM-IV criteria for schizoaffective or bipolar disorder that was deemed treatment-resistant were randomly assigned to clozapine add-on treatment (N=19) or treatment as usual (no clozapine) (N=19) and followed up for 1 year. Patients received monthly ratings on the Brief Psychiatric Rating Scale, Clinical Global Impression scale, Bech-Rafaelsen Mania Scale, Hamilton Depression Rating Scale, Scale for the Assessment of Positive Symptoms, Scale for the Assessment of Negative Symptoms, Abnormal Involuntary Movement Scale, and a 40-item side effect checklist. Differences between treatment groups were assessed according to a pattern-mix random-regression model. An additional analysis compared group differences in rating scale scores against relative time in the study. RESULTS: Significant between-group differences were found in scores on all rating scales except the Hamilton depression scale. Total medication use over 1 year significantly decreased in the clozapine group. No significant differences between groups in somatic complaints were noted. The subjects with nonpsychotic bipolar I disorder who received clozapine showed a degree of improvement similar to that of the entire clozapine-treated group. Clozapine dose was significantly higher for the patients with schizoaffective illness than for those with bipolar disorder. CONCLUSIONS: The results of this study support clozapine's independent mood-stabilizing property. They demonstrate that clozapine use was associated with significant clinical improvement relative to treatment as usual.
This article has been cited by other articles:
|
|
|
|
 
A. H. Young and J. I. Newham
Lithium in maintenance therapy for bipolar disorder.
J Psychopharmacol,
March 1, 2006;
20(2 Suppl):
17 - 22.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. S. E. Hellewell
A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
J Psychopharmacol,
March 1, 2006;
20(2 Suppl):
39 - 45.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. A Marken and R. W Pies
Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles
Ann. Pharmacother.,
February 1, 2006;
40(2):
276 - 285.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Khanna, E. Vieta, B. Lyons, F. Grossman, M. Eerdekens, and M. Kramer
Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study
The British Journal of Psychiatry,
September 1, 2005;
187(3):
229 - 234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Drug treatments for bipolar disorder: 2 - Maintenance, prevention and special situations
DTB,
May 1, 2005;
43(5):
33 - 37.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Goodwin and A. H. Young
Using guidelines in real clinical situations: clozapine and breast feeding in bipolar disorder
J Psychopharmacol,
May 1, 2005;
19(3):
317 - 318.
[PDF]
|
|
|
|
|
|
|
L. Citrome, R. Josiassen, N. Bark, D. E. Salazar, and S. Mallikaarjun
Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate
J. Clin. Pharmacol.,
January 1, 2005;
45(1):
89 - 93.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.H. Belmaker
Bipolar Disorder
N. Engl. J. Med.,
July 29, 2004;
351(5):
476 - 486.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tohen, T. A. Ketter, C. A. Zarate, T. Suppes, M. Frye, L. Altshuler, J. Zajecka, L. M. Schuh, R. C. Risser, E. Brown, et al.
Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania and Maintenance of Remission: A 47-Week Study
Am J Psychiatry,
July 1, 2003;
160(7):
1263 - 1271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Goodwin
Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
June 1, 2003;
17(2):
149 - 173.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. H. Rapaport and D. J. Hales
Relapse Prevention and Bipolar Disorder: A Focus on Bipolar Depression
Focus,
January 1, 2003;
1(1):
15 - 31.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Bibliography for Bipolar Disorder
Focus,
January 1, 2003;
1(1):
32 - 33.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M.A. Hirschfeld, C. L. Bowden, M. J. Gitlin, P. E. Keck, R. H. Perlis, T. Suppes, M. E. Thase, and K. D. Wagner
Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Focus,
January 1, 2003;
1(1):
64 - 110.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Y. Meltzer, L. Alphs, A. I. Green, A. C. Altamura, R. Anand, A. Bertoldi, M. Bourgeois, G. Chouinard, M. Z. Islam, J. Kane, et al.
Clozapine Treatment for Suicidality in Schizophrenia: International Suicide Prevention Trial (InterSePT)
Arch Gen Psychiatry,
January 1, 2003;
60(1):
82 - 91.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. S. Sachs, F. Grossman, S. N. Ghaemi, A. Okamoto, and C. L. Bowden
Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety
Am J Psychiatry,
July 1, 2002;
159(7):
1146 - 1154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Zarate
The Case of Sam: Multidisciplinary Perspectives: Psychiatric Medication: What Medications Should Be Prescribed?
Psychiatr Serv,
October 1, 2001;
52(10):
1325 - 1328.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. COOKSON
Use of antipsychotic drugs and lithium in mania
The British Journal of Psychiatry,
June 1, 2001;
178
(41):
s148 - s156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fahy and T. J. Fahy
Induction of manic symptoms by novel antipsychotics
The British Journal of Psychiatry,
June 1, 2000;
176
(6):
597 - 597.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Add-On Clozapine for Treatment-Resistant Patients with a History of Mania
Journal Watch Psychiatry,
October 1, 1999;
1999(1001):
15 - 15.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
